Results 61 to 70 of about 3,621,575 (254)

The potential benefits of assessing post-cardiopulmonary exercise testing (CPET) in aging: a narrative review

BMC Sports Science, Medicine and Rehabilitation, 2023
Cardiopulmonary exercise testing (CPET) is an important tool to measure the cardiopulmonary fitness of an individual and has been widely used in athletic, clinical and research settings.
Zi Xiang Lim, Bibek Gyanwali, Janjira Soh, Angela S. Koh, Jorming Goh   +4 more
doaj   +1 more source

Multimodal Imaging of Hypoxia, Metabolism and pH in Feline Sarcoma Using Hyperpolarized 13C MRI and PET

Advanced Science, EarlyView.
This work presents a clinically deployable simultaneous PET/MRI workflow which integrates hyperpolarized 13C imaging of metabolism and extracellular pH with [18F]FMISO PET to characterize hypoxia, acidosis, and metabolic reprogramming in feline sarcoma.
Martin Grashei, Tanja Groll, Stephanie Kahl, Silke Baer, Elisabeth Bliemsrieder, Frits H. A. van Heijster, Andre Wendlinger, Pascal Wodtke, Jorge Cabello, Susan Notohamiprodjo, Christian Lohrmann, Markus Schwaiger, Wolfgang A. Weber, Katja Steiger, Andrea Meyer‐Lindenberg, Johannes Hirschberger, Christine Baumgartner, Franz Schilling   +17 more
wiley   +1 more source

Cardiopulmonary exercise test in medical and biological practice (literature review)

Acta Biomedica Scientifica
Most tests assess physiology at rest, whereas many symptoms occur with physical exertion, and physical activity is an integral part of healthy functioning and quality of life of a person. Today, cardiopulmonary exercise testing is considered the standard
A. B. Kiryanov, I. S. Kozhevnikova, A. A. Farkova, N. Yu. Anikina, E. V. Yurieva, A. I. Amelina   +5 more
doaj   +1 more source

According to normal weight, overweight and obesity groups (n = 1,594), physiological responses to cardiopulmonary exercise testing.

, 2021
According to normal weight, overweight and obesity groups (n = 1,594), physiological responses to cardiopulmonary exercise testing.
Antônio Ricardo de Toledo Gagliardi (11250549), Marcello Romiti (6070808), Evandro Fornias Sperandio (4650058), Victor Zuniga Dourado (4648570), Bárbara de Barros Gonze (11250540), Rodolfo Leite Arantes (6070814), Thatiane Lopes Valentim Di Paschoale Ostolin (11250543), Alan Carlos Brisola Barbosa (11250546), Agatha Caveda Matheus (6070793)   +8 more
core   +1 more source

Alkylating Agent–Induced FANCL Impairment Damages Pulmonary Arterial, Venous, and Microvascular Endothelial Cells and Predisposes to PAH/PVOD

Advanced Science, EarlyView.
This study establishes a novel cisplatin‐induced rat model of PAH/PVOD and identifies a conserved mechanistic axis—FANCL impairment, DNA damage accumulation, and endothelial dysfunction—triggered by cisplatin or mitomycin C across pulmonary arteries, veins, and microvessels.
Shiyun Liu, Yufei Sun, Xinlei Wu, Haixia Chen, Shaocong Mo, Zichong Li, Yiwei Gong, Xiaoqian Shan, Yuanqi Li, Yaru Guan, Junqi Zhu, Han Yan, Min Du, Feng Wei, Peixin Ou, Ziyi Wang, Chenting Zhang, Lei Xu, Wenju Lu, Jian Wang, Kai Yang   +20 more
wiley   +1 more source

Cardiopulmonary Exercise Testing (CPET) Guided Sub-Anaerobic Threshold Rehabilitation in MELAS Syndrome: A Case Report. [PDF]

Kaohsiung J Med Sci
The Kaohsiung Journal of Medical Sciences, EarlyView.
Tsai YL, Cheng KY, Lu YS, Lin KL.
europepmc   +2 more sources

Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease. [PDF]

PLoS ONE, 2012
BACKGROUND: Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its value in ACHD has limitations.
Oktay Tutarel, Agnieszka Denecke, Stefanie M Bode-Böger, Jens Martens-Lobenhoffer, Svjetlana Lovric, Johann Bauersachs, Bernhard Schieffer, Mechthild Westhoff-Bleck, Jan T Kielstein   +8 more
doaj   +1 more source

Cardiopulmonary responses at the gas exchange threshold during exercise testing in ME/CFS patients and controls.

, 2022
Cardiopulmonary responses at the gas exchange threshold during exercise testing in ME/CFS patients and controls.
Jin-Mann S. Lin (6717686), Elizabeth R. Unger (6717698), Ryan J. Dougherty (1312281), Michael J. Falvo (4437265), Yang Chen (9737), Dane B. Cook (7853774), Stephanie VanRiper (12245599), Jacob B. Lindheimer (5855882)   +7 more
core   +1 more source

Development of Versatile Nanoparticle System for Efficient Drug Delivery into Pulmonary Endothelium

Advanced Science, EarlyView.
Pediatric acute respiratory distress syndrome (PARDS) suppresses the FOXF1 transcription factor and disrupts lung development. This study shows that the FOXF1‐activating small‐molecule compound, TanFe[F], can be precisely delivered to lung endothelial cells using the innovative LEDD nanoparticle system.
Afzaal N. Mohammed, Zicheng Deng, Arnab Misra, Marcus Orzabal, Ananya Kondapally, Enhong Li, Jonathan Do, Ying‐Wei Lan, Fatemeh Kohram, Hunter Blackburn, Andreas Damianos, Tanya V. Kalin, Vladimir V. Kalinichenko   +12 more
wiley   +1 more source

Utility of Cardiopulmonary Exercise Testing in Chronic Obstructive Pulmonary Disease: A Review

, 2023
Mehrdad Behnia,1 Kathy E Sietsema2 1Pulmonary and Critical Care, University of Central Florida, Orlando, FL, USA; 2The Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, CA, USACorrespondence: Mehrdad Behnia, Pulmonary ...
Behnia M, Sietsema KE
core